The AP-1 inhibitor T-5224 suppresses MM growth both in vitro and in vivo by downregulating GPX4 and SLC7A11, effects that are reversed by ferrostatin-1, confirming a ferroptotic mechanism. The gene discussed is SLC7A11; the disease is Miyoshi myopathy.